Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-nbp
/
Novabridge Biosciences ADR
NBP
Add to Watchlist
2.140
USD
+0.150
+7.54%
Close 07/02, 13:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
246.92M
Market Cap
Loss
P/E TTM
Novabridge Biosciences ADR
2.140
+0.150
+7.54%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
More Details of Company
Novabridge Biosciences ADR Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Novabridge Biosciences ADR
Name
Name/Position
Position
Shareholding
Change
Mr. Wei Fu
Mr. Wei Fu
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Chun Kwok (Alan) Au
Mr. Chun Kwok (Alan) Au
Independent Director
Independent Director
--
--
Mr. Chia-Hung (Conor) Yang
Mr. Chia-Hung (Conor) Yang
Independent Director
Independent Director
--
--
Dr. Phillip Dennis, M.D., Ph.D.
Dr. Phillip Dennis, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Xi-Yong (Sean) Fu, Ph.D.
Dr. Xi-Yong (Sean) Fu, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Robert Lenz, M.D., Ph.D.
Dr. Robert Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
,
,
Independent Director
Independent Director
--
--
,
,
Chief Business Development Officer, Director
Chief Business Development Officer, Director
--
--
Mr. Kyler Lei
Mr. Kyler Lei
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Claire Xu
Mr. Claire Xu
Senior Vice President - Clinical Development
Senior Vice President - Clinical Development
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wei Fu
Mr. Wei Fu
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Chun Kwok (Alan) Au
Mr. Chun Kwok (Alan) Au
Independent Director
Independent Director
--
--
Mr. Chia-Hung (Conor) Yang
Mr. Chia-Hung (Conor) Yang
Independent Director
Independent Director
--
--
Dr. Phillip Dennis, M.D., Ph.D.
Dr. Phillip Dennis, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Xi-Yong (Sean) Fu, Ph.D.
Dr. Xi-Yong (Sean) Fu, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Robert Lenz, M.D., Ph.D.
Dr. Robert Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Novabridge Biosciences ADR?
The top five shareholders of Novabridge Biosciences ADR are: Mr. Wei Fu